Moxostad (Moxonidine)

Moxonidine, the active ingredient in Moxostad, is an Imidazoline receptor agonist presented as a tablet for oral use. It treats hypertension by lowering blood pressure in adult patients. GNH USA supplies Moxostad as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxonidine acts on central imidazoline I1 receptors to control elevated blood pressure. - Essential hypertension: reduces systolic and diastolic pressure in primary hypertension. - Secondary hypertension: may be added to therapy when high blood pressure results from another condition. - Resistant hypertension: can complement existing regimens to achieve target blood pressure levels.

Moxonidine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Dry mouth: sensation of oral dryness without obvious cause. - Fatigue: feeling unusually tired or weak. - Dizziness: light‑headedness, especially when standing quickly. - Headache: mild to moderate pain in the head region. - Nausea: upset stomach with urge to vomit. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure that may cause fainting. - Bradycardia: unusually slow heart rate. - Liver enzyme elevation: abnormal liver function test results. - Allergic reactions: rash, itching, swelling, or breathing difficulty. - Arrhythmia: irregular heart rhythm. - Depression: mood changes or depressive symptoms.

Before initiating therapy, certain safety considerations are recommended. - Monitor blood pressure: check regularly to avoid excessive hypotension. - Assess renal function: adjust dose if kidney impairment is present. - Avoid abrupt discontinuation: sudden stop may trigger rebound hypertension. - Caution in elderly: increased sensitivity to blood‑pressure lowering effects. - Store at room temperature: keep in the original pack, protect from moisture.

Moxonidine can interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Combined with other antihypertensives (e.g., ACE inhibitors, beta‑blockers) may cause excessive hypotension. - Concomitant use with central sympatholytics (e.g., clonidine) increases risk of severe blood‑pressure drop. - Potassium‑sparing diuretics may potentiate hypotensive effect. - Strong CYP2D6 inhibitors may raise plasma concentrations of moxonidine. - Alcohol: additive sedative and hypotensive effects.

Moderate Interactions (Monitor Closely): - NSAIDs may reduce antihypertensive efficacy. - Loop or thiazide diuretics may alter electrolyte balance. - Lithium levels can increase, requiring monitoring. - Tricyclic antidepressants may enhance hypotensive response.